LONDON--(BUSINESS WIRE)--Technavio has been monitoring the contract development and manufacturing organization (CDMO) outsourcing market and it is poised to grow by USD 44.17 billion during 2020-2024, ...

Pluri, an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) division ...

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Organization (CMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland)The ...

The "mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region ...

Outsourcing offers expertise beyond facilities, but sponsors need strategic CDMO partnerships for peptide therapeutics, cell ...

CHATHAM, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development ...

The medical device industry is experiencing significant changes, and contract development and manufacturing organizations (CDMOs) are playing a crucial role. This Q&A explores Albert Weng's role as ...

The "Contract Manufacturing of Medical Devices: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for contract manufacturing of medical devices is estimated ...

HAIFA, Israel, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote global ...